NextCure, Inc.

NXTC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$56-$63-$75-$69
Dep. & Amort.$3$4$4$7
Deferred Tax$0$0$0-$24
Stock-Based Comp.$6$8$10$10
Change in WC$5-$2$4-$5
Other Non-Cash$1-$0$3$24
Operating Cash Flow-$41-$53-$54-$57
Investing Activities
PP&E Inv.-$0-$1-$2-$2
Net Acquisitions$0$0-$0-$0
Inv. Purchases-$48-$74-$35-$156
Inv. Sales/Matur.$104$114$105$195
Other Inv. Act.$0$0$0$0
Investing Cash Flow$55$39$68$37
Financing Activities
Debt Repay.$0$0$0-$3
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0-$3
Forex Effect$0$0$0$0
Net Chg. in Cash$15-$14$14-$24
Supplemental Information
Beg. Cash$13$27$12$36
End Cash$28$13$27$12
Free Cash Flow-$41-$54-$56-$60